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Previous studies using chicken ovalbumin upstream promoter transcription factor
(COUP-TF)-interacting protein 2 (Ctip2) knockout mice have demonstrated the
importance of this transcription factor for the formation of the epidermal
permeability barrier. Because sphingolipids are crucial in generating the barrier,
in this issue Indra and colleagues show, perhaps not surprisingly, that Ctip2 has a
key role in sphingolipid metabolism. Thus, Ctip2 gene ablation alters sphingolipid
levels and expression of genes encoding sphingolipid-metabolizing enzymes, in
some cases by direct binding to their promoters. Abnormalities in Ctip2 could
therefore underlie skin disorders characterized by an aberrant epidermal perme-
ability barrier.
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The epidermal permeability barrier is
critical for terrestrial life, preventing
excessive water loss and consequent
dehydration. The epidermal permeabil-
ity barrier is formed from lipids secreted
as lamellar bodies from granular kerati-
nocytes and processed by simulta-
neously secreted lipid-metabolizing
enzymes. Lipids involved in forming
the barrier include neutral lipids, fatty
acids, and sphingolipids, including cer-
amide. Indeed, ceramides comprise
B50% (by weight) of the lipids of the
lamellar structure of the stratum cor-
neum (Elias et al., 2008), and the
epidermis synthesizes unique omega-
O-acylceramides containing amide-
linked very long chain fatty acids,
which appear to be crucial for proper
functioning of the epidermis (Behne
et al., 2000; and reviewed in Uchida
and Holleran, 2008).
In a previous article published in the
Journal of Investigative Dermatology,
Indra and colleagues demonstrated
that the transcription factor, chicken
ovalbumin upstream promoter transcrip-
tion factor (COUP-TF)-interacting pro-
tein-2 (Ctip2), is required for proper
formation of the epidermal permeability
barrier (Golonzhka et al., 2009). Using
two different knockout models, a Ctip2
global knockout and a conditional
epidermal (keratinocyte)-specific Ctip2
knockout, these authors showed that
loss of Ctip2 resulted in abnormal epi-
dermal function, including delayed and/
or aberrant permeability barrier forma-
tion, as well as hypoplasia and dysregu-
lated differentiation of keratinocytes
comprising the epidermis (Golonzhka
et al., 2009). Certain of these effects
were cell autonomous, such that they
were observed in both the global and
conditional knockout mouse models
(increased transepidermal water loss),
whereas others appeared to be the result
of crosstalk between the epidermis and
other skin components (hypoplasia). In
both knockout models, however, barrier
function of the epidermis was com-
promised (as indicated by enhanced
transepidermal water loss), and to such
a degree that the global Ctip2 knockout
mice died perinatally. In this initial
article, neutral lipids, as well as the
expression of their synthetic enzymes,
were found to be decreased (Golonzhka
et al., 2009).
Sphingolipids also have a key role in
the formation of a proper epidermal
permeability barrier (reviewed in Elias
et al., 2008 and Uchida and Holleran,
2008). Therefore, and perhaps not
surprisingly, in this issue of the Journal
of Investigative Dermatology, Wang
et al. (2012) demonstrate that the
global Ctip2 knockout mice exhibit
alterations (usually decreases) in cera-
mide levels, with corresponding (in
general) increases in sphingomyelin
levels during embryonic development
(embryonic day 16.5 to 18.5). These
changes were also accompanied by
differences in the expression of genes
encoding sphingolipid-metabolizing
enzymes, including Lass1, 2, 3, and 6,
Sptlc1 and 3, Gba2, Ugcg, Asah2,
SphK1 and 2, and Acer1 (decreased)
and Sgms2 (increased). Other genes
were unaffected, including Acer2 and
3, Asah1, Lass4 and 5, Sptlc2, Kdsr,
Degs1, and Sgms1. These genes and
their contributions to ceramide bio-
synthesis and metabolism are shown in
Figure 1. By chromatin immunoprecipi-
tation (ChIP) assays, some of these
genes, namely Gba2 and Lass 2, were
found to be direct targets of Ctip2.
These studies in knockout mouse
models suggest a crucial role for Ctip2
in regulating formation of the epidermal
permeability barrier. Therefore, it seems
likely that dysregulation of this transcrip-
tion factor (through changes in levels
and/or activation) could underlie skin
disorders characterized by abnormal
barrier function. Indeed, Ganguli-Indra
et al. (2009a) have recently observed
that CTIP2 immunoreactivity is increased
in patients with atopic dermatitis and
allergic contact dermatitis. On the basis
of the emerging idea that permeability
defects can result in altered immunity
(reviewed in De Benedetto et al., 2012),
it seems possible that dysregulated
CTIP2 could also underlie certain forms
of dermatitis, psoriasis, and ichthyosis, as
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well as atopy, with manifestations in
other organs, such as the respiratory
tract (allergic rhinitis and asthma) and
the gastrointestinal tract (food allergies)
(De Benedetto et al., 2012). CTIP2 is also
upregulated in poorly differentiated head
and neck squamous cell carcinomas,
suggesting a possible role in tumor
formation and/or progression (Ganguli-
Indra et al., 2009b). In addition, recent
studies in epidermal-specific Ctip2
knockout mice indicate that Ctip2 is
involved in keratinocyte migration and
skin wound healing, such that condi-
tional knockout mice heal more slowly
than control mice (Liang et al., 2012).
Finally, it should be noted that in the
current report, epidermal lipoxygenase-
3 (eLOX3), although technically not a
sphingolipid-metabolizing enzyme, was
also found to be a direct target of Ctip2.
Thus, the transcription factor directly
bound to the promoter region of the
gene, Aloxe3, in ChIP assays, and
eLOX3 expression was decreased in
the knockout mice. eLOX3 is a lipox-
ygenase and together with 12-lipoxy-
genase functions to metabolize fatty
acids (e.g., arachidonic acid) to hydro-
xyepoxyalcohol products. eLOX3 also
appears to be involved in ceramide
processing in the skin as well as in the
synthesis of hepoxilins (Krieg et al.,
2013). Importantly, loss-of-function muta-
tions in human ALOXE3 are known to
underlie, in part, one form of ichthyosis
(autosomal recessive congenital ichthy-
osis; Elias et al., 2008), suggesting that
abnormalities in its upstream regulator
CTIP2 could also result in ichthyotic
skin disorders.
Abnormal Ctip2 may
underlie epidermal
disorders with an
aberrant barrier.
In summary, CTIP2 has an important
role in the formation and maintenance
of the epidermal permeability barrier
by modulating epidermal lipid composi-
tion through regulating the expression
of several lipid-metabolizing enzymes.
Ctip2 modifies both neutral lipids
(Golonzhka et al., 2009) and sphingo-
lipids (Wang et al., 2013) in the
epidermis, such that lack of the gene
results in barrier disruption and increased
transepidermal water loss (Golonzhka
et al., 2009). Dysregulation of CTIP2
may be linked to skin disorders
characterized by epidermal permea-
bility abnormalities, indicating the
importance of further studies of this
key epidermal lipid-regulating transcrip-
tion factor in animal models and in
patients with dermatological diseases.
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Figure 1. Sphingolipid metabolism and the enzymes mediating key steps. Shown are the enzymatic
steps in ceramide metabolism with the substrates and products involved. Enzyme/gene names are as
in the Wang et al. (2012) article in this issue. dh-sphingosine, dihydrosphingosine; ketodh-sphingosine,
ketodihydrosphingosine.
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